Palladyne AI Stock Soars 11% On Results Day After Raising Its Revenue Floor

Quarterly sales rose 895%, but the operating loss widened and management cautioned about the timing of government software revenue.

Share
Palladyne AI Stock Soars 11% On Results Day After Raising Its Revenue Floor

Palladyne AI, which develops robotic-autonomy software, soared 11.30% to $3.94 in Tuesday trading, as of 10:13 a.m. ET, adding $20 million in market value. The gain came on results day, when the company raised its annual revenue floor in an SEC filing and reported sharply higher quarterly sales.

Sales Climb, Losses Widen

Palladyne recorded $8.6 million in third-quarter revenue, an 895% increase. The revised 2026 forecast sets $25 million as the minimum revenue expectation, with $27 million still the maximum.

The operating loss grew from $8.1 million to $13.4 million. Research on Gremlin-X contributed to that loss.

Management also tempered the commercialization picture on the earnings call. Military deployments had not yet led to large software purchases, management cautioned, and it could not predict when drone software would produce material government revenue. The higher annual sales floor therefore sat alongside a caution about when that part of the business would generate substantial sales.

A Recovery Within A Steep Retreat

Tuesday's advance put PDYN on pace for its third gain of 10% or more this month and its third consecutive daily gain. The company's market value stood at about $194.4 million in Tuesday trading.

The recovery followed a difficult stretch. Through Monday's close, Palladyne shares were down 17% for the year, while the S&P 500 had risen 10%.

Palladyne had fallen 30% over the previous month. Before Tuesday's session, the stock was 65% below its highest closing price of the past year, despite the recent recovery.

The results paired a higher revenue floor with a larger operating loss; management's caution centered on when military deployments would turn into substantial software purchases.

Sources

More on Palladyne AI

All Palladyne AI (PDYN) coverage →